Author:
Yu D,Scott C,Jia W W,De Benedetti A,Williams B J,Fazli L,Wen Y,Gleave M,Nelson C,Rennie P S
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference39 articles.
1. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95 (17): 1276–1299.
2. Trump D, Lau YK . Chemotherapy of prostate cancer: present and future. Curr Urol Rep 2003; 4 (3): 229–232.
3. Latham JP, Searle PF, Mautner V, James ND . Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. Cancer Res 2000; 60 (2): 334–341.
4. Uchida A, O’Keefe DS, Bacich DJ, Molloy PL, Heston WD . In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy. Urology 2001; 58 (2 Suppl 1): 132–139.
5. Yu D, Jia WW, Gleave ME, Nelson CC, Rennie PS . Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter. Prostate 2004; 59 (4): 370–382.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献